Global (United States, European Union and China) Oral Proteins and Peptides Market Research Report 2019-2025

Publisher Name :
Date: 30-Jul-2019
No. of pages: 112
Inquire Before Buying

Proteins and Peptides are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases, which can be administered orally are known as oral peptide and protein-based drugs.

The oral protein and peptide-based therapeutics market for diabetes is expected to grow considerably in the near future, owing to factors such as increase in incidence rate of diabetes caused by rapid urbanization and sedentary lifestyle.

The U.S. is anticipated to generate the highest revenue in the oral proteins and peptides market in 2023. The rest of the world possesses high market potential for the growth of the market, owing to increase in awareness about oral peptide and protein therapeutics based treatment and rise in oral peptide and protein therapeutics applications. This region is anticipated to experience fast-paced growth, in terms of development and use of protein therapeutics.

The diabetes application is anticipated to occupy the largest share in the oral proteins and peptides market in 2023 owing to the high adoption of oral insulin, surge in geriatric population, and rise in prevalence of diabetes.

In 2019, the market size of Oral Proteins and Peptides is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.

In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Oral Proteins and Peptides.

This report studies the global market size of Oral Proteins and Peptides, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).

This study presents the Oral Proteins and Peptides sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.

For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:

- Allergan

- AstraZeneca

- Biocon

- Generex Biotechnology

- Novo Nordisk

- Synergy Pharmaceuticals

- Tarsa Therapeutics

- Sanofi

- Hoffmann-La Roche

- Synthetic Biologics

- Hovione

- Novartis

Market Segment by Product Type

- Linaclotide

- Plecanatide

- Calcitonin

- Insulin

- Octreotide

Market Segment by Application

- Gastric & Digestive Disorders

- Bone Diseases

- Diabetes

- Hormonal Disorders

Key Regions split in this report: breakdown data for each region.

- United States

- China

- European Union

- Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:

- To analyze and research the Oral Proteins and Peptides status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.

- To present the key Oral Proteins and Peptides manufacturers, presenting the sales, revenue, market share, and recent development for key players.

- To split the breakdown data by regions, type, companies and applications

- To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.

- To identify significant trends, drivers, influence factors in global and regions

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Oral Proteins and Peptides are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

Global (United States, European Union and China) Oral Proteins and Peptides Market Research Report 2019-2025

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Oral Proteins and Peptides Market Size Growth Rate by Type (2019-2025)
1.3.2 Linaclotide
1.3.3 Plecanatide
1.3.4 Calcitonin
1.3.5 Insulin
1.3.6 Octreotide
1.4 Market Segment by Application
1.4.1 Global Oral Proteins and Peptides Market Share by Application (2019-2025)
1.4.2 Gastric & Digestive Disorders
1.4.3 Bone Diseases
1.4.4 Diabetes
1.4.5 Hormonal Disorders
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Proteins and Peptides Market Size
2.1.1 Global Oral Proteins and Peptides Revenue 2014-2025
2.1.2 Global Oral Proteins and Peptides Sales 2014-2025
2.2 Oral Proteins and Peptides Growth Rate by Regions
2.2.1 Global Oral Proteins and Peptides Sales by Regions 2014-2019
2.2.2 Global Oral Proteins and Peptides Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Oral Proteins and Peptides Sales by Manufacturers
3.1.1 Oral Proteins and Peptides Sales by Manufacturers 2014-2019
3.1.2 Oral Proteins and Peptides Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Oral Proteins and Peptides Revenue by Manufacturers (2014-2019)
3.2.2 Oral Proteins and Peptides Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Oral Proteins and Peptides Market Concentration Ratio (CR5 and HHI)
3.3 Oral Proteins and Peptides Price by Manufacturers
3.4 Key Manufacturers Oral Proteins and Peptides Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Oral Proteins and Peptides Market
3.6 Key Manufacturers Oral Proteins and Peptides Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 Linaclotide Sales and Revenue (2014-2019)
4.1.2 Plecanatide Sales and Revenue (2014-2019)
4.1.3 Calcitonin Sales and Revenue (2014-2019)
4.1.4 Insulin Sales and Revenue (2014-2019)
4.1.5 Octreotide Sales and Revenue (2014-2019)
4.2 Global Oral Proteins and Peptides Sales Market Share by Type
4.3 Global Oral Proteins and Peptides Revenue Market Share by Type
4.4 Oral Proteins and Peptides Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Oral Proteins and Peptides Sales by Application
6 United States
6.1 United States Oral Proteins and Peptides Breakdown Data by Company
6.2 United States Oral Proteins and Peptides Breakdown Data by Type
6.3 United States Oral Proteins and Peptides Breakdown Data by Application
7 European Union
7.1 European Union Oral Proteins and Peptides Breakdown Data by Company
7.2 European Union Oral Proteins and Peptides Breakdown Data by Type
7.3 European Union Oral Proteins and Peptides Breakdown Data by Application
8 China
8.1 China Oral Proteins and Peptides Breakdown Data by Company
8.2 China Oral Proteins and Peptides Breakdown Data by Type
8.3 China Oral Proteins and Peptides Breakdown Data by Application
9 Rest of World
9.1 Rest of World Oral Proteins and Peptides Breakdown Data by Company
9.2 Rest of World Oral Proteins and Peptides Breakdown Data by Type
9.3 Rest of World Oral Proteins and Peptides Breakdown Data by Application
9.4 Rest of World Oral Proteins and Peptides Breakdown Data by Countries
9.4.1 Rest of World Oral Proteins and Peptides Sales by Countries
9.4.2 Rest of World Oral Proteins and Peptides Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.1.4 Oral Proteins and Peptides Product Introduction
10.1.5 Allergan Recent Development
10.2 AstraZeneca
10.2.1 AstraZeneca Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.2.4 Oral Proteins and Peptides Product Introduction
10.2.5 AstraZeneca Recent Development
10.3 Biocon
10.3.1 Biocon Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.3.4 Oral Proteins and Peptides Product Introduction
10.3.5 Biocon Recent Development
10.4 Generex Biotechnology
10.4.1 Generex Biotechnology Company Details
10.4.2 Company Description and Business Overview
10.4.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.4.4 Oral Proteins and Peptides Product Introduction
10.4.5 Generex Biotechnology Recent Development
10.5 Novo Nordisk
10.5.1 Novo Nordisk Company Details
10.5.2 Company Description and Business Overview
10.5.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.5.4 Oral Proteins and Peptides Product Introduction
10.5.5 Novo Nordisk Recent Development
10.6 Synergy Pharmaceuticals
10.6.1 Synergy Pharmaceuticals Company Details
10.6.2 Company Description and Business Overview
10.6.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.6.4 Oral Proteins and Peptides Product Introduction
10.6.5 Synergy Pharmaceuticals Recent Development
10.7 Tarsa Therapeutics
10.7.1 Tarsa Therapeutics Company Details
10.7.2 Company Description and Business Overview
10.7.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.7.4 Oral Proteins and Peptides Product Introduction
10.7.5 Tarsa Therapeutics Recent Development
10.8 Sanofi
10.8.1 Sanofi Company Details
10.8.2 Company Description and Business Overview
10.8.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.8.4 Oral Proteins and Peptides Product Introduction
10.8.5 Sanofi Recent Development
10.9 Hoffmann-La Roche
10.9.1 Hoffmann-La Roche Company Details
10.9.2 Company Description and Business Overview
10.9.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.9.4 Oral Proteins and Peptides Product Introduction
10.9.5 Hoffmann-La Roche Recent Development
10.10 Synthetic Biologics
10.10.1 Synthetic Biologics Company Details
10.10.2 Company Description and Business Overview
10.10.3 Sales, Revenue and Market Share of Oral Proteins and Peptides
10.10.4 Oral Proteins and Peptides Product Introduction
10.10.5 Synthetic Biologics Recent Development
10.11 Hovione
10.12 Novartis
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Oral Proteins and Peptides Sales Channels
11.2.2 Oral Proteins and Peptides Distributors
11.3 Oral Proteins and Peptides Customers
12 Market Forecast
12.1 Global Oral Proteins and Peptides Sales and Revenue Forecast 2019-2025
12.2 Global Oral Proteins and Peptides Sales Forecast by Type
12.3 Global Oral Proteins and Peptides Sales Forecast by Application
12.4 Oral Proteins and Peptides Forecast by Regions
12.4.1 Global Oral Proteins and Peptides Sales Forecast by Regions 2019-2025
12.4.2 Global Oral Proteins and Peptides Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables and Figures
Figure Oral Proteins and Peptides Product Picture
Table Oral Proteins and Peptides Key Market Segments
Table Major Manufacturers Oral Proteins and Peptides Covered in This Report
Table Global Oral Proteins and Peptides Market Size Growth Rate by Type 2019-2025 (K Pcs) & (Million US$)
Figure Global Oral Proteins and Peptides Sales Market Shar by Type 2014-2025
Figure Linaclotide Figures
Table Major Manufacturers of Linaclotide
Figure Plecanatide Figures
Table Major Manufacturers of Plecanatide
Figure Calcitonin Figures
Table Major Manufacturers of Calcitonin
Figure Insulin Figures
Table Major Manufacturers of Insulin
Figure Octreotide Figures
Table Major Manufacturers of Octreotide
Table Global Oral Proteins and Peptides Market Share by Application 2019-2025 (K Pcs)
Figure Gastric & Digestive Disorders Use Case
Figure Bone Diseases Use Case
Figure Diabetes Use Case
Figure Hormonal Disorders Use Case
Figure Oral Proteins and Peptides Report Years Considered
Figure Global Oral Proteins and Peptides Market Size 2014-2025 (Million US$)
Figure Global Oral Proteins and Peptides Sales 2014-2019 (K Pcs)
Table Global Oral Proteins and Peptides Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
Table Global Oral Proteins and Peptides Sales by Regions 2014-2019 (K Pcs)
Table Global Oral Proteins and Peptides Sales Market Share by Regions 2014-2019
Figure Global Oral Proteins and Peptides Sales Market Share by Regions 2014-2019
Figure Global Oral Proteins and Peptides Sales Market Share by Regions in 2019
Table Global Oral Proteins and Peptides Revenue by Regions 2014-2019 (Million US$)
Table Global Oral Proteins and Peptides Revenue Market Share by Regions 2014-2019
Figure Global Oral Proteins and Peptides Revenue Market Share by Regions 2014-2019
Figure Global Oral Proteins and Peptides Revenue Market Share by Regions in 2019
Table Market Top Trends
Table Global Oral Proteins and Peptides Sales by Manufacturers (2014-2019) (K Pcs)
Table Global Oral Proteins and Peptides Sales Share by Manufacturers (2014-2019)
Figure Global Oral Proteins and Peptides Sales Share by Manufacturers in 2019
Table Oral Proteins and Peptides Revenue by Manufacturers (2014-2019) (Million USD)
Table Oral Proteins and Peptides Revenue Share by Manufacturers (2014-2019)
Figure Oral Proteins and Peptides Value Share by Manufacturers in 2019
Table Global Oral Proteins and Peptides Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Oral Proteins and Peptides Price (2014-2019) (USD/Pcs)
Table Key Manufacturers Oral Proteins and Peptides Plants/Factories Distribution
Table Key Manufacturers Oral Proteins and Peptides Area Served
Table Date of Key Manufacturers Enter into Oral Proteins and Peptides Market
Table Key Manufacturers Oral Proteins and Peptides Product Type
Table Mergers & Acquisitions, Expansion Plans
Table Global Linaclotide Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Plecanatide Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Calcitonin Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Insulin Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Octreotide Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
Table Global Oral Proteins and Peptides Sales by Type (2014-2019) (K Pcs)
Table Global Oral Proteins and Peptides Sales Share by Type (2014-2019)
Figure Global Oral Proteins and Peptides Sales Market Share by Type (2014-2019)
Figure Global Oral Proteins and Peptides Sales Market Share by Type in 2018
Table Global Oral Proteins and Peptides Revenue by Type (2014-2019) (Million US$)
Table Global Oral Proteins and Peptides Revenue Share by Type (2014-2019)
Figure Global Oral Proteins and Peptides Revenue Market Share by Type (2014-2019)
Figure Global Oral Proteins and Peptides Revenue Market Share by Type in 2018
Table Oral Proteins and Peptides Price by Type 2014-2019 (USD/Pcs)
Table Global Oral Proteins and Peptides Sales by Application (2014-2019) (K Pcs)
Table Global Oral Proteins and Peptides Sales Share by Application (2014-2019)
Figure Global Sales Oral Proteins and Peptides Market Share by Application (2014-2019)
Figure Global Sales Oral Proteins and Peptides Market Share by Application (2014-2019)
Figure United States Oral Proteins and Peptides Sales Growth Rate 2014-2019 (K Pcs)
Figure United States Oral Proteins and Peptides Revenue Growth Rate 2014-2019 (Million US$)
Table United States Oral Proteins and Peptides Sales by Company (2014-2019) (K Pcs)
Table United States Oral Proteins and Peptides Sales Market Share by Company (2014-2019)
Figure United States Oral Proteins and Peptides Sales Market Share by Company in 2019
Table United States Oral Proteins and Peptides Sales by Type (2014-2019) (K Pcs)
Table United States Oral Proteins and Peptides Sales Market Share by Type (2014-2019)
Figure United States Oral Proteins and Peptides Market Share by Type in 2019
Table United States Oral Proteins and Peptides Sales by Application (2014-2019) (K Pcs)
Table United States Oral Proteins and Peptides Sales Market Share by Application (2014-2019)
Figure United States Oral Proteins and Peptides Market Share by Application in 2019
Figure European Union Oral Proteins and Peptides Sales Growth Rate 2014-2019 (K Pcs)
Figure European Union Oral Proteins and Peptides Revenue Growth Rate 2014-2019 (Million US$)
Table European Union Oral Proteins and Peptides Sales by Company (2014-2019) (K Pcs)
Table European Union Oral Proteins and Peptides Sales Market Share by Company (2014-2019)
Figure European Union Oral Proteins and Peptides Sales Market Share by Company in 2019
Table European Union Oral Proteins and Peptides Sales by Type (2014-2019) (K Pcs)
Table European Union Oral Proteins and Peptides Sales Market Share by Type (2014-2019)
Figure 2018 European Union Oral Proteins and Peptides Market Share by Type
Table European Union Oral Proteins and Peptides Sales by Application (2014-2019) (K Pcs)
Table European Union Oral Proteins and Peptides Sales Market Share by Application (2014-2019)
Figure 2018 European Union Oral Proteins and Peptides Market Share by Application
Figure China Oral Proteins and Peptides Sales Growth Rate 2014-2019 (K Pcs)
Figure China Oral Proteins and Peptides Revenue Growth Rate 2014-2019 (Million US$)
Table China Oral Proteins and Peptides Sales by Company (2014-2019) (K Pcs)
Table China Oral Proteins and Peptides Sales Market Share by Company (2014-2019)
Figure China Oral Proteins and Peptides Sales Market Share by Company in 2019
Table China Oral Proteins and Peptides Sales by Type (2014-2019) (K Pcs)
Table China Oral Proteins and Peptides Sales Market Share by Type (2014-2019)
Figure China Oral Proteins and Peptides Market Share by Type in 2019
Table China Oral Proteins and Peptides Sales by Application (2014-2019) (K Pcs)
Table China Oral Proteins and Peptides Sales Market Share by Application (2014-2019)
Figure China Oral Proteins and Peptides Market Share by Application in 2019
Figure Rest of World Oral Proteins and Peptides Sales Growth Rate 2014-2019 (K Pcs)
Figure Rest of World Oral Proteins and Peptides Revenue Growth Rate 2014-2019 (Million US$)
Table Rest of World Oral Proteins and Peptides Sales by Company (2014-2019) (K Pcs)
Table Rest of World Oral Proteins and Peptides Sales Market Share by Company (2014-2019)
Figure Rest of World Oral Proteins and Peptides Sales Market Share by Company in 2019
Table Rest of World Oral Proteins and Peptides Sales by Type (2014-2019) (K Pcs)
Table Rest of World Oral Proteins and Peptides Sales Market Share by Type (2014-2019)
Figure Rest of World Oral Proteins and Peptides Market Share by Type in 2019
Table Rest of World Oral Proteins and Peptides Sales by Application (2014-2019) (K Pcs)
Table Rest of World Oral Proteins and Peptides Sales Market Share by Application (2014-2019)
Figure Rest of World Oral Proteins and Peptides Market Share by Application in 2019
Table Rest of World Oral Proteins and Peptides Sales by Countries (2014-2019) (K Pcs)
Table Rest of World Oral Proteins and Peptides Sales Market Share by Countries (2014-2019)
Figure Rest of World Oral Proteins and Peptides Sales Market Share by Countries in 2019
Table Rest of World Oral Proteins and Peptides Revenue by Countries (2014-2019) (Million US$)
Table Rest of World Oral Proteins and Peptides Revenue Market Share by Countries (2014-2019)
Figure Rest of World Oral Proteins and Peptides Revenue Market Share by Countries in 2019
Figure Japan Oral Proteins and Peptides Sales Growth Rate (2014-2019) (K Pcs)
Figure Japan Oral Proteins and Peptides Revenue Growth Rate (2014-2019) (K Pcs)
Figure Korea Oral Proteins and Peptides Sales Growth Rate (2014-2019) (K Pcs)
Figure Korea Oral Proteins and Peptides Revenue Growth Rate (2014-2019) (K Pcs)
Figure India Oral Proteins and Peptides Sales Growth Rate (2014-2019) (K Pcs)
Figure India Oral Proteins and Peptides Revenue Growth Rate (2014-2019) (K Pcs)
Figure Southeast Asia Oral Proteins and Peptides Sales Growth Rate (2014-2019) (K Pcs)
Figure Southeast Asia Oral Proteins and Peptides Revenue Growth Rate (2014-2019) (K Pcs)
Table Allergan Company Details
Table Allergan Description and Business Overview
Table Allergan Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Allergan Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Allergan Oral Proteins and Peptides Sales Market Share in Global Market
Table Allergan Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Description and Business Overview
Table AstraZeneca Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table AstraZeneca Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table AstraZeneca Oral Proteins and Peptides Sales Market Share in Global Market
Table AstraZeneca Recent Development
Table Biocon Company Details
Table Biocon Description and Business Overview
Table Biocon Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Biocon Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Biocon Oral Proteins and Peptides Sales Market Share in Global Market
Table Biocon Recent Development
Table Generex Biotechnology Company Details
Table Generex Biotechnology Description and Business Overview
Table Generex Biotechnology Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Generex Biotechnology Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Generex Biotechnology Oral Proteins and Peptides Sales Market Share in Global Market
Table Generex Biotechnology Recent Development
Table Novo Nordisk Company Details
Table Novo Nordisk Description and Business Overview
Table Novo Nordisk Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Novo Nordisk Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Novo Nordisk Oral Proteins and Peptides Sales Market Share in Global Market
Table Novo Nordisk Recent Development
Table Synergy Pharmaceuticals Company Details
Table Synergy Pharmaceuticals Description and Business Overview
Table Synergy Pharmaceuticals Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Synergy Pharmaceuticals Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Synergy Pharmaceuticals Oral Proteins and Peptides Sales Market Share in Global Market
Table Synergy Pharmaceuticals Recent Development
Table Tarsa Therapeutics Company Details
Table Tarsa Therapeutics Description and Business Overview
Table Tarsa Therapeutics Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Tarsa Therapeutics Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Tarsa Therapeutics Oral Proteins and Peptides Sales Market Share in Global Market
Table Tarsa Therapeutics Recent Development
Table Sanofi Company Details
Table Sanofi Description and Business Overview
Table Sanofi Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Sanofi Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Sanofi Oral Proteins and Peptides Sales Market Share in Global Market
Table Sanofi Recent Development
Table Hoffmann-La Roche Company Details
Table Hoffmann-La Roche Description and Business Overview
Table Hoffmann-La Roche Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Hoffmann-La Roche Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Hoffmann-La Roche Oral Proteins and Peptides Sales Market Share in Global Market
Table Hoffmann-La Roche Recent Development
Table Synthetic Biologics Company Details
Table Synthetic Biologics Description and Business Overview
Table Synthetic Biologics Oral Proteins and Peptides Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
Table Synthetic Biologics Oral Proteins and Peptides Sales Growth Rate (2014-2019)
Table Synthetic Biologics Oral Proteins and Peptides Sales Market Share in Global Market
Table Synthetic Biologics Recent Development
Table Hovione Company Details
Table Novartis Company Details
Figure Oral Proteins and Peptides Value Chain
Table Oral Proteins and Peptides Distributors List
Table Oral Proteins and Peptides Customers List
Table Global Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs) & (Million US$)
Figure Global Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Table Global Oral Proteins and Peptides Sales Forecast by Type 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Sales Forecast by Type 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Sales Market Share Forecast by Type 2019-2025
Table Global Oral Proteins and Peptides Sales Forecast by Application 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Sales Forecast by Application 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Sales Market Share Forecast by Application 2019-2025
Table Global Oral Proteins and Peptides Sales Forecast by Regions 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Sales Forecast by Regions 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Sales Market Share Forecast by Regions 2019-2025
Table Global Oral Proteins and Peptides Revenue Forecast by Regions 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Revenue Forecast by Regions 2019-2025 (K Pcs)
Figure Global Oral Proteins and Peptides Revenue Market Share Forecast by Regions 2019-2025
Figure United States Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure United States Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Figure European Union Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure European Union Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Figure China Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure China Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Figure Japan Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure Japan Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Figure Korea Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure Korea Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Figure India Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure India Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Figure Southeast Asia Oral Proteins and Peptides Sales Forecast 2019-2025 (K Pcs)
Figure Southeast Asia Oral Proteins and Peptides Revenue Forecast 2019-2025 (Million US$)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs